Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Azd4547
2. N-(5-(2-(3,5-dimethoxyphenyl)ethyl)-2h-pyrazol-3-yl)-4-(3,5-diemthylpiperazin-1-yl)benzamide
1. Azd4547
2. 1035270-39-3
3. Azd 4547
4. N-(5-(3,5-dimethoxyphenethyl)-1h-pyrazol-3-yl)-4-((3s,5r)-3,5-dimethylpiperazin-1-yl)benzamide
5. 2167og1ekj
6. Chebi:63453
7. Rel-n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethyl-1-piperazinyl]benzamide
8. Kb-74810
9. N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
10. N-{3-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-5-yl}-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
11. N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl}-4-(cis-3,5-dimethylpiperazin-1-yl)benzamide
12. N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl}-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
13. Unii-2167og1ekj
14. 66t
15. Schembl63884
16. Absk091
17. N-(5-(3,5-dimethoxyphenethyl)-1h-pyrazol-3-yl)-4-((3r,5s)-rel-3,5-dimethylpiperazin-1-yl)benzamide
18. Absk-091
19. Gtpl7707
20. Schembl15250892
21. Dtxsid80145887
22. Azd 4547 [who-dd]
23. Amy16612
24. Ex-a1578
25. Mfcd22580423
26. Nsc764239
27. Nsc765338
28. Nsc799346
29. S2801
30. Zinc95616598
31. Akos024464898
32. Bcp9000364
33. Ccg-269382
34. Cs-0971
35. Db12247
36. Nsc-764239
37. Nsc-765338
38. Nsc-799346
39. Ncgc00346713-01
40. Ncgc00346713-05
41. Ac-28442
42. As-17054
43. Hy-13330
44. Rel-n-(5-(3,5-dimethoxyphenethyl)-1h-pyrazol-3-yl)-4-((3r,5s)-3,5-dimethylpiperazin-1-yl)benzamide
45. Sw219341-1
46. J-000994
47. J-524217
48. Q27074746
49. Benzamide, N-(5-(2-(3,5-dimethoxyphenyl)ethyl)-1h-pyrazol-3-yl)-4-((3r,5s)-3,5-dimethyl-1-piperazinyl)-, Rel-
50. N-(5-(3,5-dimethoxyphenethyl)-1h-pyrazol-3-yl)-4-((3r,5s)-3,5-dimethylpiperazin-1-yl)benzamide, Rel-
51. N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-[(3s,5r)-3,5-dimethylpiperazin-1-yl]benzamide
52. N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin -1-yl]benzamide
53. N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
| Molecular Weight | 463.6 g/mol |
|---|---|
| Molecular Formula | C26H33N5O3 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 8 |
| Exact Mass | 463.25833993 g/mol |
| Monoisotopic Mass | 463.25833993 g/mol |
| Topological Polar Surface Area | 91.5 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 622 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
84
PharmaCompass offers a list of AZD4547 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AZD4547 manufacturer or AZD4547 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AZD4547 manufacturer or AZD4547 supplier.
PharmaCompass also assists you with knowing the AZD4547 API Price utilized in the formulation of products. AZD4547 API Price is not always fixed or binding as the AZD4547 Price is obtained through a variety of data sources. The AZD4547 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AZD4547 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AZD4547, including repackagers and relabelers. The FDA regulates AZD4547 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AZD4547 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AZD4547 supplier is an individual or a company that provides AZD4547 active pharmaceutical ingredient (API) or AZD4547 finished formulations upon request. The AZD4547 suppliers may include AZD4547 API manufacturers, exporters, distributors and traders.
AZD4547 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AZD4547 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AZD4547 GMP manufacturer or AZD4547 GMP API supplier for your needs.
A AZD4547 CoA (Certificate of Analysis) is a formal document that attests to AZD4547's compliance with AZD4547 specifications and serves as a tool for batch-level quality control.
AZD4547 CoA mostly includes findings from lab analyses of a specific batch. For each AZD4547 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AZD4547 may be tested according to a variety of international standards, such as European Pharmacopoeia (AZD4547 EP), AZD4547 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AZD4547 USP).
